[ad_1]
Despite record levels for stock prices and rising bullishness on Wall Street, JPMorgan Chase didn’t stray from its more conservative outlook on the risk to the economy from inflation, geopolitical upheaval and other potential pitfalls.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...